BioMarin Recruits Amgen R&D’s Friberg, Roche Dealmaker Sabry To Leadership Team
Third And Fourth C-Suite Changes Since November
The company, in its new profitable era, is bringing in new leadership, with Amgen VP of medical affairs for rare diseases Greg Friberg and recently retired Roche Partnering head James Sabry.
